Preclinical activity of fluvastatin‐loaded self‐nanoemulsifying delivery system against breast cancer models: Emphasis on apoptosis

Regulation of Autophagy Progress via Lysosomal Depletion by Fluvastatin Nanoparticle Treatment in Breast Cancer Cells

(2020) Hanan Elimam et al.   ACS Omega

Rosuvastatin lyophilized tablets loaded with flexible chitosomes for improved drug bioavailability, anti-hyperlipidemic and anti-oxidant activity

(2020) Tarek A. Ahmed et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

(2019) Amal Kamal Abdel-Aziz et al.   HAEMATOLOGICA

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

(2019) Amal Kamal Abdel-Aziz et al.   EUROPEAN JOURNAL OF CANCER

Genetic Ablation of Calcium-independent Phospholipase A2γ Exacerbates Glomerular Injury in Adriamycin Nephrosis in Mice

(2019) Hanan Elimam et al.   Scientific Reports

Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3- d ]pyrimidine-based dual EGFR/HER2 inhibitors

(2018) Sandra N. Milik et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Development of a fluvastatin-loaded self-nanoemulsifying system to maximize therapeutic efficacy in human colorectal carcinoma cells

(2018) Hibah M. Aldawsari et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau

(2018) Jean-Philippe Courade et al.   ACTA NEUROPATHOLOGICA

Statins anticancer targeted delivery systems: re-purposing an old molecule

(2017) Sally Safwat et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

(2017) et al.   JAMA Oncology

Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy

(2017) Zuozhang Yang et al.   EBioMedicine

Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: A short follow-up

(2017) Nervana Samy et al.   Cancer Biomarkers

Genetic Ablation of Calcium-independent Phospholipase A2γ Induces Glomerular Injury in Mice

(2016) Hanan Elimam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Self-nanoemulsifying drug delivery system of sinapic acid: In vitro and in vivo evaluation

(2016) Faiyaz Shakeel et al.   JOURNAL OF MOLECULAR LIQUIDS

Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system

(2016) Faiyaz Shakeel et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells

(2015) YUAN-YUAN SHEN et al.   Molecular Medicine Reports

Modulation of Imatinib Cytotoxicity by Selenite in HCT116 Colorectal Cancer Cells

(2014) Amal Kamal Abdel-Aziz et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

(2014) P Jiang et al.   BRITISH JOURNAL OF CANCER

Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro

(2014) Minyong Kang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Calcium-independent Phospholipase A2γ Enhances Activation of the ATF6 Transcription Factor during Endoplasmic Reticulum Stress

(2014) Hanan Elimam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Statins inhibit tumor progressionviaan enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer

(2013) S. Ishikawa et al.   INTERNATIONAL JOURNAL OF CANCER

HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway

(2013) X-F Qi et al.   Cell Death & Disease

Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells

(2012) G. Pelaia et al.   CELL PROLIFERATION

Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents

(2012) M. Thurnher et al.   CLINICAL CANCER RESEARCH

Complement-mediated Activation of Calcium-independent Phospholipase A2γ

(2012) Hanan Elimam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting tumor cell metabolism with statins

(2012) J W Clendening et al.   ONCOGENE

Involvement of Chk1–Cdc25A-cyclin A/CDk2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells

(2011) Yong-Sheng Tu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin

(2011) Maja Misirkic et al.   PHARMACOLOGICAL RESEARCH

Modified Annexin V/Propidium Iodide Apoptosis Assay For Accurate Assessment of Cell Death

(2011) Aja M. Rieger et al.   Jove-Journal of Visualized Experiments

Inhibition of Autophagy Enhances Anticancer Effects of Atorvastatin in Digestive Malignancies

(2010) P.-M. Yang et al.   CANCER RESEARCH

Nanocarrier for the enhanced bioavailability of a cardiovascular agent: In vitro, pharmacodynamic, pharmacokinetic and stability assessment

(2010) Vikas Bali et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

(2010) S. L. Holbeck et al.   MOLECULAR CANCER THERAPEUTICS

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

(2009) Elisabeth R. Garwood et al.   BREAST CANCER RESEARCH AND TREATMENT

Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death

(2009) Emeli M. Nilsson et al.   EXPERIMENTAL CELL RESEARCH